New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

BACKGROUND: Triple negative breast cancer (TNBC) is a heterogeneous disease with aggressive behavior and an unfavorable prognosis rate. Due to the lack of surface receptors, TNBC must be intensely investigated in order to establish a suitable treatment for patients with this pathology. Chemoresistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciocan-Cartita, Cristina Alexandra, Jurj, Ancuta, Zanoaga, Oana, Cojocneanu, Roxana, Pop, Laura-Ancuta, Moldovan, Alin, Moldovan, Cristian, Zimta, Alina Andreea, Raduly, Lajos, Pop-Bica, Cecilia, Buse, Mihail, Budisan, Liviuta, Virag, Piroska, Irimie, Alexandru, Diaz, Sandra Martha Gomez, Berindan-Neagoe, Ioana, Braicu, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664031/
https://www.ncbi.nlm.nih.gov/pubmed/33187552
http://dx.doi.org/10.1186/s13046-020-01736-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664031/
https://www.ncbi.nlm.nih.gov/pubmed/33187552
http://dx.doi.org/10.1186/s13046-020-01736-2

Ejemplares similares